warfarin hexadecyl ether
model of lipophilic agent for drug targeting to tumor cells with increased LDL receptor activity; structure in first source
Networked:
0
relevant articles (
0 outcomes,
0 trials/studies)
for this Bio-Agent,
Comments
Bio-Agent Context: Research Results